KS

Keshavrao Shrirangrao Borkar

Active Director Director DIN 07389179
DIN 07389179 First appointment Jan 2016 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Keshavrao Shrirangrao Borkar

Data last updated:

Keshavrao Shrirangrao Borkar is a Director at Gpk Pharmaceutical Industry Private Limited (since 2016). The company operates in Pharma.

DIN 07389179
Primary Designation Director
Industry Pharma
First Appointment 14 Jan 2016
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Jan 20162016Active

Board colleagues of Keshavrao Shrirangrao Borkar

Directorship timeline

Open interactive timeline →
Gpk Pharmaceutical Industry Private Limited
Premium access

Shareholding and investment profile for Keshavrao Shrirangrao Borkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Keshavrao Shrirangrao Borkar

Keshavrao Shrirangrao Borkar currently holds 1 directorship: Gpk Pharmaceutical Industry Private Limited (Director, since 14 Jan 2016).

Keshavrao Shrirangrao Borkar was first appointed on 14 Jan 2016 as Director at Gpk Pharmaceutical Industry Private Limited.

The current boards of Keshavrao Shrirangrao Borkar's companies include Gaukarna Pravin Kendrekar (Gpk Pharmaceutical Industry Private Limited), Pravinkumar Sunderrao Kendrekar (Gpk Pharmaceutical Industry Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available